Rickey James Paul

CIK 00016062432 companiesSEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001606243

Recent Transactions

50 trades

Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−108,999→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−137→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-20−26,761→ 31,200 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−143→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-20−31,200→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−1,214→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−112,500→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−78,000→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−836→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−112,945→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-07$6.51/sh+857→ 39,113 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-07$3.23/sh+18,286→ 57,563 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-07$5.02/sh+398→ 57,961 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-07−18,286→ 1,214 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-07−398→ 137 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-07−164→ 836 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-07−857→ 143 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-07−1→ 108,999 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-07−7,055→ 112,945 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-07$7.55/sh+1→ 31,201 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-07$13.20/sh+7,055→ 38,256 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-07$11.31/sh+164→ 39,277 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-01-26−73,764→ 1,000 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-01-26$11.31/sh+44,000→ 44,000 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-01-26−44,000→ 1,000 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-01-26$6.51/sh+73,764→ 73,764 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-01-26$25.00/sh−44,000→ 0 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-01-26$22.31/sh−73,764→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-01-25$6.51/sh+236→ 236 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-01-25$22.00/sh−236→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-01-25−236→ 74,764 total
Award
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-01-04+78,000→ 78,000 total
Award
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-01-04+31,200→ 31,200 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-19$5.02/sh+15,213→ 15,213 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2023-12-19−15,213→ 535 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-19$19.21/sh−15,213→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-18$5.02/sh+1,800→ 1,800 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2023-12-18−1,800→ 15,748 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-18$19.00/sh−1,800→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2023-12-15−45,387→ 17,548 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-15$5.02/sh+45,387→ 45,387 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-15$19.09/sh−45,387→ 0 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-14$19.00/sh−11,600→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-14$5.02/sh+11,600→ 11,600 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2023-12-14−11,600→ 62,935 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-06$3.23/sh+6,446→ 6,446 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2023-12-06−6,446→ 19,500 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-06$16.08/sh−6,446→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2023-12-05−418→ 25,946 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-05$16.01/sh−418→ 0 total

Companies

Recent Filings

Address

C/O IMMUNE DESIGN CORP. 1616 EASTLAKE AVE. E., SUITE 310

SEATTLE, WA, 98102

View on SEC.gov